Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China · Delayed Price · Currency is CNY 10.82
-0.20 (-1.81%)
Apr 9, 2026, 3:00 PM CST
SHA:603998 Revenue
Hunan Fangsheng Pharmaceutical had revenue of 419.07M CNY in the quarter ending September 30, 2025, a decrease of -4.26%. This brings the company's revenue in the last twelve months to 1.68B, down -4.47% year-over-year. In the year 2024, Hunan Fangsheng Pharmaceutical had annual revenue of 1.78B with 9.15% growth.
Revenue (ttm)
1.68B
Revenue Growth
-4.47%
P/S Ratio
2.82
Revenue / Employee
931.29K
Employees
1,807
Market Cap
4.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.78B | 148.95M | 9.15% |
| Dec 31, 2023 | 1.63B | -163.46M | -9.12% |
| Dec 31, 2022 | 1.79B | 225.03M | 14.36% |
| Dec 31, 2021 | 1.57B | 288.21M | 22.54% |
| Dec 31, 2020 | 1.28B | 185.01M | 16.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.20B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.27B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| Bide Pharmatech | 1.32B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Tibet Weixinkang Medicine | 1.17B |
| LanZhou Foci Pharmaceutical | 895.75M |